Theodora E. Markatseli

1.0k total citations
36 papers, 739 citations indexed

About

Theodora E. Markatseli is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Theodora E. Markatseli has authored 36 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 9 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Theodora E. Markatseli's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (10 papers) and Spondyloarthritis Studies and Treatments (9 papers). Theodora E. Markatseli is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (10 papers) and Spondyloarthritis Studies and Treatments (9 papers). Theodora E. Markatseli collaborates with scholars based in Greece, United States and Sweden. Theodora E. Markatseli's co-authors include Alexandros A. Drosos, Paraskevi V. Voulgari, Alexandros A. Drosos, Yannis Alamanos, Aikaterini Zioga, Charalampos Papagoras, P.V. Voulgari, Ioannis Antonopoulos, Dimitrios Daoussis and Sofia Exarchou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Theodora E. Markatseli

34 papers receiving 723 citations

Peers

Countries citing papers authored by Theodora E. Markatseli

Since Specialization

Citations

This map shows the geographic impact of Theodora E. Markatseli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodora E. Markatseli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodora E. Markatseli more than expected).

Fields of papers citing papers by Theodora E. Markatseli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodora E. Markatseli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodora E. Markatseli. The network helps show where Theodora E. Markatseli may publish in the future.

Co-authorship network of co-authors of Theodora E. Markatseli

This figure shows the co-authorship network connecting the top 25 collaborators of Theodora E. Markatseli. A scholar is included among the top collaborators of Theodora E. Markatseli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodora E. Markatseli. Theodora E. Markatseli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study 2023 ·Clinical Rheumatology ·(unknown), A. Georgiadis, Constantinos C. Tellis, Iro Rapti, Theodora E. Markatseli, Vasileios Xydis, Alexandros D. Tselepis, Alexandros A. Drosos, Paraskevi V. Voulgari	2
2	The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study 2022 ·Heart and Vessels ·(unknown), Theodora E. Markatseli, A. Georgiadis, Vasileios Xydis, Haralampos Milionis, Alexandros A. Drosos, Paraskevi V. Voulgari	7
3	Cardiovascular Magnetic Resonance Detects Inflammatory Cardiomyopathy in Symptomatic Patients with Inflammatory Joint Diseases and a Normal Routine Workup 2022 ·Journal of Clinical Medicine ·George Markousis‐Mavrogenis, Μaria Bonou, (unknown), Genovefa Kolovou, Aliki I. Venetsanopoulou, Theodora E. Markatseli, (unknown), (unknown), Paraskevi V. Voulgari, Sophie Mavrogeni	4
4	Role of Hepcidin in Anemia of Chronic Disease in Rheumatoid Arthritis 2021 ·SHILAP Revista de lepidopterología ·(unknown), Eleni Bairaktari, (unknown), (unknown), (unknown), Theodora E. Markatseli, (unknown), (unknown), Paraskevi V. Voulgari	8
5	Pleural effusion in psoriatic arthritis patients: a case series and review of the literature 2021 ·Clinical Rheumatology ·Aliki I. Venetsanopoulou, Theodora E. Markatseli, (unknown), (unknown), Maria I. Argyropoulou, Alexandros A. Drosos, Paraskevi V. Voulgari	1
6	Biologic Therapies and Autoimmune Phenomena 2021 ·SHILAP Revista de lepidopterología ·Alexandros A. Drosos, Eleftherios Pelechas, Evripidis Kaltsonoudis, Theodora E. Markatseli, Paraskevi V. Voulgari	16
7	Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin 2020 ·SHILAP Revista de lepidopterología ·Aliki I. Venetsanopoulou, Theodora E. Markatseli, (unknown), A. Georgiadis, (unknown), Alexandros A. Drosos, Paraskevi V. Voulgari	2
8	Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis 2020 ·Current Rheumatology Reviews ·(unknown), Theodora E. Markatseli, Paraskevi V. Voulgari, Alexandros A. Drosos	3
9	B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis 2019 ·Rheumatology International ·Ioannis Antonopoulos, Dimitrios Daoussis, Maria‐Eleni Lalioti, Theodora E. Markatseli, Alexandros A. Drosos, Stavros Taraviras, Andrew P. Andonopoulos, Stamatis‐Nick C. Liossis	8
10	The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital 2019 ·PLoS ONE ·Evripidis Kaltsonoudis, Eleftherios Pelechas, Alexandra Papoudou‐Bai, Theodora E. Markatseli, Moses Elisaf, Paraskevi V. Voulgari, Alexandros A. Drosos	6
11	THU0132 EVALUATION OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICAL AGENTS: 3-MONTH FOLLOW-UP 2019 ·Annals of the Rheumatic Diseases ·(unknown), Theodora E. Markatseli, A. Georgiadis, Vasileios Xydis, Haralampos Milionis, Alexandros A. Drosos, Paraskevi V. Voulgari	0
12	Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence 2018 ·The Journal of Rheumatology ·(unknown), Theodora E. Markatseli, Kyriaki Boki, Ioannis Papadopoulos, Fotini N. Skopouli, Paraskevi V. Voulgari, Loukas Settas, (unknown), Alexios Iliopoulos, Pierre Geborek, Alexandros A. Drosos, Dimitrios T. Boumpas, Prodromos Sidiropoulos	34
13	Effect of Hydroxychloroquine on the Lipid Profile of Patients with Sjögren Syndrome 2014 ·The Journal of Rheumatology ·(unknown), Theodora E. Markatseli, (unknown), Paraskevi V. Voulgari, Alexandros A. Drosos	20
14	In transit Recurrence of Merkel Cell Carcinoma Associated with Polyarthritis Effectively Treated with Immunocryosurgery 2014 ·Acta Dermato Venereologica ·Paraskevi V. Voulgari, Georgios Gaitanis, Theodora E. Markatseli, Werner Kempf, Ioannis D. Bassukas	6
15	Cardiovascular risk profile in patients with spondyloarthritis 2013 ·Joint Bone Spine ·Charalampos Papagoras, Theodora E. Markatseli, (unknown), Yannis Alamanos, Anastasia Zikou, Paraskevi V. Voulgari, Dimitrios N. Kiortsis, Alexandros A. Drosos	54
16	Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival 2013 ·Seminars in Arthritis and Rheumatism ·(unknown), Theodora E. Markatseli, Paraskevi V. Voulgari, Kyriaki Boki, Ioannis Papadopoulos, Loukas Settas, (unknown), Fotini N. Skopouli, Alexios Iliopoulos, George Βertsias, Pierre Geborek, Alexandros A. Drosos, Dimitrios T. Boumpas, Prodromos Sidiropoulos	72
17	Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. 2010 ·PubMed ·Theodora E. Markatseli, (unknown), Paraskevi V. Voulgari, Aikaterini Zioga, Alexandros A. Drosos	26
18	Maintained clinical response of infliximab treatment in ankylosing spondylitis: A 6-year long-term study 2010 ·Joint Bone Spine ·(unknown), Theodora E. Markatseli, Paraskevi V. Voulgari, Alexandros A. Drosos	13
19	Sustained Clinical Response in Psoriatic Arthritis Patients Treated with Anti-TNF Agents: A 5-year Open-Label Observational Cohort Study 2010 ·Seminars in Arthritis and Rheumatism ·(unknown), Theodora E. Markatseli, Charalampos Papagoras, Paraskevi V. Voulgari, Yannis Alamanos, Alexandros A. Drosos	33
20	Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study 2010 ·The Journal of Rheumatology ·Theodora E. Markatseli, Paraskevi V. Voulgari, Yannis Alamanos, Alexandros A. Drosos	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact